Autologous MHC-dependent leukaemia-reactive T lymphocytes in a patient with chronic myeloid leukaemia

Leukemia

Volumn 10, Issue 3, 1996, Pages 483-487

  Coleman, S ^a   Fisher, J ^a   Hoy, T ^a   Burnett, A K ^a   Lim, S H ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Autologous; CML; MHC dependent T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HLA ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN; RECOMBINANT INTERLEUKIN 2;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLONAL ANERGY; CYTOLYSIS; EFFECTOR CELL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029913123     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hale G, Waldmann H. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplant for malignant diseases. Bone Marrow Transplant 1994; 13: 597-611.
2. Kolb HJ, Mitteruller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
3. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R. Anti-leukemia effect of graft-versus-host disease in recipients of allogeneic marrow grafts. New Engl J Med 1979; 300: 1068-1073.
4. Miescher S, Whiteside TL, Moretta L, von Fliedner V. Clonal and frequency analyses of tumor-infiltrating T-lymphocytes from human solid tumors. J Immunol 1987; 138: 4004-4011.
5. Topalian SL, Solomon D, Rosenberg SA. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 1989; 142: 3714-3725.
6. Hale G, Bright S, Chumbley C, Hoang T, Metcalf D, Munro AJ, Waldmann H. Removal of T-cells from bone marrow for transplantation: a monoclonal anti-lymphocyte antibody that fixes human complement. Blood 1983; 62: 873-882.
7. Lim SH, Worman CP, Jewell A, Tsakona C, Giles FJ, Goldstone AH. Lymphocyte activation and serine esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias. Cancer Immunol Immunother 1991; 33: 133-137.
8. Lefkovits I, Waldmann H. Limiting Dilution Analysis of Cells in the Immune System. Cambridge University Press: Cambridge, 1979, p 60.
9. Miescher S, Whiteside TL, Carrell S, von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors. Effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 1986; 136: 1899-1907.
10. Shimizu Y, Iwatsuki S, Herberman RB, Whiteside TL. Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors Cancer Immunol Immunother 1991; 32: 280-288.
11. Robbins PF, El-Gamil M, Kawakami Y, Rosenberg SA. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy Cancer Res 1994; 54: 3124-3126.